NeuroTracker: Funding, Investors & Team (Sep 2026)
NeuroTracker is a Montreal-based neurotech company owned by Nothing Artificial, specializing in assessing and enhancing cognitive functions for human performance and wellness. The technology was developed by world-leading neuroscientist Professor Jocelyn Faubert, and has over 40 peer reviewed studies demonstrating its efficacy. Starting with Manchester United, NeuroTracker spread across elite sports in the NFL, NHL, EPL, NBA, and MLB, as well as elite military groups, F1 and eSports teams. NeuroTracker recently joined the Digital Therapeutics Alliance, and won partnership competitions with the US Airforce and Bayer. NeuroTracker is now established as a telehealth solution, allowing clients to train, monitor and manage any number of users at home or on the go. It is used widely by clinicians and therapists in the neurovision and rehabilitation markets.
NeuroTracker has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Oct 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NeuroTracker Company Profile and Key Stats
Latest funding round on record: Oct 2024.
NeuroTracker Funding Rounds
NeuroTracker Founders and Leadership Team
Contact details for the NeuroTracker team: 1 of 1 has an email address on file.
Start 14-day free trial →NeuroTracker Funding Compared to Other Biotechnology Startups
NeuroTracker's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NeuroTracker in Biotechnology and Montréal
Companies Similar to NeuroTracker
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
NeuroTracker Funding FAQs
What does NeuroTracker do?
NeuroTracker is a Montreal-based neurotech company owned by Nothing Artificial, specializing in assessing and enhancing cognitive functions for human performance and wellness. The technology was developed by world-leading neuroscientist Professor Jocelyn Faubert, and has over 40 peer reviewed studies demonstrating its efficacy. Starting with Manchester United, NeuroTracker spread across elite sports in the NFL, NHL, EPL, NBA, and MLB, as well as elite military groups, F1 and eSports teams. NeuroTracker recently joined the Digital Therapeutics Alliance, and won partnership competitions with the US Airforce and Bayer. NeuroTracker is now established as a telehealth solution, allowing clients to train, monitor and manage any number of users at home or on the go. It is used widely by clinicians and therapists in the neurovision and rehabilitation markets.
How much funding has NeuroTracker raised?
NeuroTracker has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Oct 2024.
When did NeuroTracker last raise funding?
NeuroTracker's most recent funding round on record is an undisclosed round of $2.0M, announced in Oct 2024.
Who founded NeuroTracker?
FundedIQ lists Christina Epifano (Founder) at NeuroTracker.
Where is NeuroTracker headquartered?
NeuroTracker is based in Montréal, Quebec, Canada.
How many employees does NeuroTracker have?
NeuroTracker is in the 11-50 employee band.
How does NeuroTracker's funding compare to other Biotechnology startups?
NeuroTracker's latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's NeuroTracker Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NeuroTracker is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.